Pharmacology Watch – October 1, 2015
October 1, 2015
View Archives Issues
-
Liraglutide Effective for Weight Loss in Diabetics
Among overweight and obese participants with type 2 diabetes, use of subcutaneous liraglutide daily compared with placebo resulted in weight loss over 56 weeks.
-
Chronic Sinusitis Recognized as Inflammatory Disease
Evidence supports daily high-volume saline irrigation along with topical corticosteroids as first-line therapy.
-
Aspirin and NSAIDs Reduce Colorectal Cancer Risk
Long-term continuous use of low-dose aspirin and long-term use of non-aspirin nonsteroidal anti-inflammatories was associated with reduced colorectal cancer risk.
-
FDA Actions
In this section: Drug to treat hypoactive sexual desire disorder in premenopausal women goes live; new drug available to prevent delayed phase chemotherapy-induced nausea and vomiting; DPP-4 inhibitors used to treat type 2 diabetes may cause severe and disabling joint pain; and evolocumab receives approval.